Observers warn of the negative health consequences if US President Donald Trump follows through on his promise to impose tariffs on pharmaceuticals. Susan Jaffe reports.

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.

Kelso Pharma builds for future growth with appointment of life sciences leader as Chief Operating OfficerKelso Pharma, the growing UK-based specialty pharmaceuticals business, has appointed life ...

Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those ...

Despite a challenging biopharmaceutical environment, Ligand Pharmaceuticals Inc (LGND) reports significant revenue growth and ...

Global Generic Pharmaceuticals Market Poised for Robust Growth: Projected to Reach $916.2 Billion by 2033 with Strong Gains in Asia-Pacific and Emerg ...

In a landmark move to strengthen access to affordable and quality medicines, improve public health, and support economic growth, the International Finance Corporation (IFC) of the World Bank Group has ...

Moreover, Downing Street has indicated that the UK will receive "preferential treatment in any further tariffs imposed" as ...

The White House on May 5, 2025 issued an executive order requiring the US Food and Drug Administration to find ways to facilitate the opening of ...

Learn more about whether Alvotech or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Minghui Pharmaceutical ('Minghui'), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ('Qilu') for the ...

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has ...